Xiong Jin

Magokdong, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Synapsin III promotes neuronal-like transdifferentiation of glioblastoma stem cells by disrupting JAG1-Notch1 interaction.

Synapsin III promotes neuronal-like transdifferentiation of glioblastoma stem cells by disrupting JAG1-Notch1 interaction.

Journal: Neuro-oncology
Published: February 24, 2025

Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling.

Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling.

Journal: Nature communications
Published: October 01, 2024

P4HB maintains Wnt-dependent stemness in glioblastoma stem cells as a precision therapeutic target and serum marker.

P4HB maintains Wnt-dependent stemness in glioblastoma stem cells as a precision therapeutic target and serum marker.

Journal: Oncogenesis
Published: August 13, 2024

MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell.

MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell.

Journal: Cell death discovery
Published: June 22, 2024

CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells.

CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells.

Journal: Cell reports. Medicine
Published: December 12, 2023

Recent advances in SERS-based immunochromatographic assay for pathogenic microorganism diagnosis: A review.

Recent advances in SERS-based immunochromatographic assay for pathogenic microorganism diagnosis: A review.

Journal: Analytica chimica acta
Published: July 27, 2023

Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.

Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.

Journal: Cancer research
Published: February 14, 2023

Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways.

Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways.

Journal: Frontiers in genetics
Published: September 27, 2022

The oncogenic JAG1 intracellular domain is a transcriptional cofactor that acts in concert with DDX17/SMAD3/TGIF2.

The oncogenic JAG1 intracellular domain is a transcriptional cofactor that acts in concert with DDX17/SMAD3/TGIF2.

Journal: Cell reports
Published: April 08, 2022

The MAP3K1/c-JUN signaling axis regulates glioblastoma stem cell invasion and tumor progression.

The MAP3K1/c-JUN signaling axis regulates glioblastoma stem cell invasion and tumor progression.

Journal: Biochemical and biophysical research communications
Published: April 05, 2022

Truncated Milk Fat Globule-EGF-like Factor 8 Ameliorates Liver Fibrosis via Inhibition of Integrin-TGFβ Receptor Interaction.

Truncated Milk Fat Globule-EGF-like Factor 8 Ameliorates Liver Fibrosis via Inhibition of Integrin-TGFβ Receptor Interaction.

Journal: Biomedicines
Published: August 30, 2021

Human Embryonic Stem Cell-Derived Wilson's Disease Model for Screening Drug Efficacy.

Human Embryonic Stem Cell-Derived Wilson's Disease Model for Screening Drug Efficacy.

Journal: Cells
Published: March 04, 2020
Showing 1-12 of 36

Last Updated: 09/26/2026